Quality assurance

Quality assurance


We have a policy, organization, employee training and others in our system to deliver reliable products to customers. 

We have a policy, organization, employee training and others in our system to deliver reliable products to customers. 

Fundamental Philosophy and Policies

Fundamental Philosophy and Policies

All employees of Taisho Pharmaceutical share the same principle and seriously engage in their work for the purpose of making consumers feel secure and satisfied. The principle is the Basic Principle of Quality Assurance under the management philosophy.

To realize this principle, the Company:

  1. At all times takes the opinions of all our consumers with the highest sincerity, and puts these into action to improve our quality and safety management;
  2. Acquires all the latest knowledge in response to the progress in science and diversification of products; and
  3. Clarifies where responsibility lies while building a cooperative organization since many departments are concerned with our business. 1 to 3 above are defined as our fundamental policy in quality assurance work.

All employees of Taisho Pharmaceutical share the same principle and seriously engage in their work for the purpose of making consumers feel secure and satisfied. The principle is the Basic Principle of Quality Assurance under the management philosophy.

To realize this principle, the Company:

  1. At all times takes the opinions of all our consumers with the highest sincerity, and puts these into action to improve our quality and safety management;
  2. Acquires all the latest knowledge in response to the progress in science and diversification of products; and
  3. Clarifies where responsibility lies while building a cooperative organization since many departments are concerned with our business. 1 to 3 above are defined as our fundamental policy in quality assurance work.

Basic Principle of Quality Assurance

Basic Principle of Quality Assurance

We constantly strive to ensure product efficacy and safety and to improve product quality from the consumers’ perspective. We are also dedicated to the peace of mind and satisfaction of our customers. This commitment to this responsibility is unwavering.

We constantly strive to ensure product efficacy and safety and to improve product quality from the consumers’ perspective. We are also dedicated to the peace of mind and satisfaction of our customers. This commitment to this responsibility is unwavering.

Policies for Quality Assurance

Policies for Quality Assurance

Stance: We will listen to consumers’ opinions and meet their expectations.
Technology: We will constantly aim for the most advanced technology, adopting a global perspective.
Management: We will constantly work on self-management activities that ensure the reliability of our activities.

Stance: We will listen to consumers’ opinions and meet their expectations.
Technology: We will constantly aim for the most advanced technology, adopting a global perspective.
Management: We will constantly work on self-management activities that ensure the reliability of our activities.

Quality Policy

Quality Policy

We continue to provide products high in quality, efficacy, and safety that earn the trust of our consumers, and bring them peace of mind and satisfaction.

We continue to provide products high in quality, efficacy, and safety that earn the trust of our consumers, and bring them peace of mind and satisfaction.

Building a system for quality assurance

Building a system for quality assurance

The Taisho Pharmaceutical Group has a social responsibility to deliver products, information and services that all consumers can trust.

The most important thing in fulfilling the responsibility is to obey laws and regulations throughout all processes such as R&D, manufacturing and sales and to make products that are effective, safe and high in quality. It is also important to ensure that, from a consumer’s perspective, the above processes are credible. The Taisho Pharmaceutical Group defines the above as quality assurance work.

In addition, we set up the Quality Assurance Headquarters independent of processes such as R&D, manufacturing and sales, and engage in quality assurance work. Many departments cooperate in quality assurance work and the Quality Assurance Headquarters functions as the leader of these departments. 

The Taisho Pharmaceutical Group has a social responsibility to deliver products, information and services that all consumers can trust.

The most important thing in fulfilling the responsibility is to obey laws and regulations throughout all processes such as R&D, manufacturing and sales and to make products that are effective, safe and high in quality. It is also important to ensure that, from a consumer’s perspective, the above processes are credible. The Taisho Pharmaceutical Group defines the above as quality assurance work.

In addition, we set up the Quality Assurance Headquarters independent of processes such as R&D, manufacturing and sales, and engage in quality assurance work. Many departments cooperate in quality assurance work and the Quality Assurance Headquarters functions as the leader of these departments. 

Operational Framework of Taisho Pharmaceutical’s Quality Assurance Headquarters
Operational Framework of Taisho Pharmaceutical’s Quality Assurance Headquarters
各段階における信頼性保証の考え方と担当部署をまとめた図。研究開発では試験保証室と知見監査室が、有効性・安全性を評価する試験の厳密性や、より高い品質の製造方法を開発できているか、それらの記録が信頼できる形で保存されているかを確認します。製造販売では品質保証部が、製品の製造と出荷の手順が適切か、品質の確保された製品が販売されているかを監視しています。また発売後の信頼性保証としては、製品の有効性や安全性に関する情報収集と評価、対応を行います。このとき医療用医薬品は医薬安全管理部と市販後調査部が、要指導・一般用医薬品はセルフメディケーション安全管理部が、それぞれ担当します。 各段階における信頼性保証の考え方と担当部署をまとめた図。研究開発では試験保証室と知見監査室が、有効性・安全性を評価する試験の厳密性や、より高い品質の製造方法を開発できているか、それらの記録が信頼できる形で保存されているかを確認します。製造販売では品質保証部が、製品の製造と出荷の手順が適切か、品質の確保された製品が販売されているかを監視しています。また発売後の信頼性保証としては、製品の有効性や安全性に関する情報収集と評価、対応を行います。このとき医療用医薬品は医薬安全管理部と市販後調査部が、要指導・一般用医薬品はセルフメディケーション安全管理部が、それぞれ担当します。

At domestic/overseas companies of Taisho Pharmaceutical Group

At domestic/overseas companies of Taisho Pharmaceutical Group

A high level of quality control and safety management is also important at Taisho Pharmaceutical Group companies in Japan or overseas. Taisho Pharmaceutical has a Group-wide management structure led by the head office.

We have also built a global pharmaceutical quality assurance system to deliver products, information and services to our overseas customers. We strengthen pharmacovigilance where the latest information on product safety is gathered and evaluation and reports are conducted accordingly. The head office and the Taisho Pharmaceutical Group companies cooperate with each other in this.

A high level of quality control and safety management is also important at Taisho Pharmaceutical Group companies in Japan or overseas. Taisho Pharmaceutical has a Group-wide management structure led by the head office.

We have also built a global pharmaceutical quality assurance system to deliver products, information and services to our overseas customers. We strengthen pharmacovigilance where the latest information on product safety is gathered and evaluation and reports are conducted accordingly. The head office and the Taisho Pharmaceutical Group companies cooperate with each other in this.

In employee training

In employee training

Taisho Pharmaceutical educates employees involved in quality control and postmarketing safety management. The educational procedures are based on GMP*1, GQP*2 and GVP*3 Ordinances.

Employees involved in quality control receive training to acquire the necessary knowledge as well as on-the-job training in on-site auditing. They also attend seminars by outside instructors. The quality assurance officer has responsibility for all of these educational programs.

Employees involved in postmarketing safety management receive education so that they are capable of performing their jobs properly. New employees are required to receive introductory training and pass the subsequent examination. These educational programs are provided under the control of a self-medication pharmacovigilance officer and a prescription drug pharmacovigilance officer.

Furthermore, all employees are provided with education on the prevention of drug-induced suffering, quality control and postmarketing safety management every year. 

Taisho Pharmaceutical educates employees involved in quality control and postmarketing safety management. The educational procedures are based on GMP*1, GQP*2 and GVP*3 Ordinances.

Employees involved in quality control receive training to acquire the necessary knowledge as well as on-the-job training in on-site auditing. They also attend seminars by outside instructors. The quality assurance officer has responsibility for all of these educational programs.

Employees involved in postmarketing safety management receive education so that they are capable of performing their jobs properly. New employees are required to receive introductory training and pass the subsequent examination. These educational programs are provided under the control of a self-medication pharmacovigilance officer and a prescription drug pharmacovigilance officer.

Furthermore, all employees are provided with education on the prevention of drug-induced suffering, quality control and postmarketing safety management every year. 

Quality is also secured by clinical trials

Quality is also secured by clinical trials

Clinical trials are studies conducted with the cooperation of patients to verify the actual effects of pharmaceuticals and other medical products.

When conducting clinical trials, we establish the framework based on relevant regulations such as the Pharmaceuticals and Medical Devices Act, ICH-GCP*4, and the GCP of the country where the trial is conducted.

For example, our policies clearly state that "the protection of the rights of trial subjects is the highest priority." Additionally, by clearly defining the responsibilities and roles of each officer and committee, we ensure the reliability of the data.

Clinical trials are studies conducted with the cooperation of patients to verify the actual effects of pharmaceuticals and other medical products.

When conducting clinical trials, we establish the framework based on relevant regulations such as the Pharmaceuticals and Medical Devices Act, ICH-GCP*4, and the GCP of the country where the trial is conducted.

For example, our policies clearly state that "the protection of the rights of trial subjects is the highest priority." Additionally, by clearly defining the responsibilities and roles of each officer and committee, we ensure the reliability of the data.

Appropriately providing information

Appropriately providing information


Operating Customer Hotline and Medical Information Center

Operating Customer Hotline and Medical Information Center

Customer Hotline receives consultation on OTC drugs available at pharmacies and drugstores, quasi-drugs that are also sold at convenience stores and supermarkets and other foods such as food for specified health uses.
Staff at Customer Hotline have qualifications as a pharmacist, a consumer affairs adviser and a hair adviser.

Customer Hotline receives consultation on OTC drugs available at pharmacies and drugstores, quasi-drugs that are also sold at convenience stores and supermarkets and other foods such as food for specified health uses.
Staff at Customer Hotline have qualifications as a pharmacist, a consumer affairs adviser and a hair adviser.

お客様119当番室、メディカルインフォメーションセンターへの問い合わせのイメージ お客様119当番室、メディカルインフォメーションセンターへの問い合わせのイメージ

Medical Information Center receives consultation on ethical drugs.
Pharmacists collaborate with the sales, development, research, factory, and branch departments to provide reliable information to our customers.

Medical Information Center receives consultation on ethical drugs.
Pharmacists collaborate with the sales, development, research, factory, and branch departments to provide reliable information to our customers.

お客様119当番室、メディカルインフォメーションセンターへの問い合わせのイメージ お客様119当番室、メディカルインフォメーションセンターへの問い合わせのイメージ

Feedback from customers to these offices is archived into a database and communicated to related departments so that it works in the development and improvement of products and improvement of services.

 

Feedback from customers to these offices is archived into a database and communicated to related departments so that it works in the development and improvement of products and improvement of services.

 

Establishing Promotion Code and transparency guidelines

Establishing Promotion Code and transparency guidelines

The Taisho Pharmaceutical Group, a drug manufacturer, needs to sincerely cooperate with medical institutions throughout the entire process from R&D to product manufacturing and launch. So we established Promotion Code, the code of conduct for securing high ethics and transparency (ensuring the absence of anything that is unclear in a process, etc.).

Whenever disclosing information, we follow Transparency Guideline for the Relation between Corporate Activities and Medical Institutions laid down by the Japan Pharmaceutical Manufacturers Association, a trade organization, and Transparency Guideline for the Relation between OTC Drug Companies’ Activities and Medical Institutions established by the Japan Self-Medication Industry.

The Taisho Pharmaceutical Group, a drug manufacturer, needs to sincerely cooperate with medical institutions throughout the entire process from R&D to product manufacturing and launch. So we established Promotion Code, the code of conduct for securing high ethics and transparency (ensuring the absence of anything that is unclear in a process, etc.).

Whenever disclosing information, we follow Transparency Guideline for the Relation between Corporate Activities and Medical Institutions laid down by the Japan Pharmaceutical Manufacturers Association, a trade organization, and Transparency Guideline for the Relation between OTC Drug Companies’ Activities and Medical Institutions established by the Japan Self-Medication Industry.

About transparency of clinical trial data

About transparency of clinical trial data

The Taisho Pharmaceutical Group discloses clinical trial data and results on the following website.

jRCT(in Japan)

ClinicalTrials.gov(in the United States)

Trial data

The Taisho Pharmaceutical Group discloses clinical trial data and results on the following website.

jRCT(in Japan)

ClinicalTrials.gov(in the United States)

Trial data

Allowing healthcare professionals, patients and many other people to access clinical trial data is important for public health as well. We believe such data should be disclosed in order to ensure the transparency of a clinical trial.

In disclosing trial data, we protect individuals’ privacy, intellectual property rights and contractual rights based on related laws and regulations in different countries.

Allowing healthcare professionals, patients and many other people to access clinical trial data is important for public health as well. We believe such data should be disclosed in order to ensure the transparency of a clinical trial.

In disclosing trial data, we protect individuals’ privacy, intellectual property rights and contractual rights based on related laws and regulations in different countries.

Notes and Additional Information
*1 GMP Ordinance: Abbreviation for Good Manufacturing Practice. Officially, it is named "Ministerial ordinance on manufacturing control and quality control standards for pharmaceuticals and quasi-drugs."
*2 GQP Ordinance: Stands for Good Quality Practice. Its official name is "Ministerial ordinance on standards for quality control for drugs, quasi-drugs, cosmetics and regenerative medicine products."
*3 GVP Ordinance: Stands for Good Vigilance Practice. Officially, the ordinance is named "Ministerial ordinance on after-sales safety management for drugs, quasi-drugs, cosmetics, medical devices and regenerative medicine products"
*4 ICH-GCP: Good Clinical Practice (GCP) defined by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Notes and Additional Information
*1 GMP Ordinance: Abbreviation for Good Manufacturing Practice. Officially, it is named "Ministerial ordinance on manufacturing control and quality control standards for pharmaceuticals and quasi-drugs."
*2 GQP Ordinance: Stands for Good Quality Practice. Its official name is "Ministerial ordinance on standards for quality control for drugs, quasi-drugs, cosmetics and regenerative medicine products."
*3 GVP Ordinance: Stands for Good Vigilance Practice. Officially, the ordinance is named "Ministerial ordinance on after-sales safety management for drugs, quasi-drugs, cosmetics, medical devices and regenerative medicine products"
*4 ICH-GCP: Good Clinical Practice (GCP) defined by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).